# Chapter 75. Membrane and Organelle Targeting of mRNAs and Local Translation

## Scope Note

This chapter explains how cytosolic mRNAs and translating ribosomes become coupled to the endoplasmic reticulum, mitochondria, chloroplasts, endosomes, and other membrane-bounded compartments. It owns signal-recognition-particle targeting, secretory and membrane-protein translation, organelle-surface association, compartment-coupled activation, and quality control at those targets. [Chapter 74](chapter1069.md) owns general transport machinery and localization grammar, [Chapter 76](chapter1071.md) owns developmental and cell-type programs, and [Chapter 103](chapter1098.md) owns neuronal and glial integration. The chapter therefore teaches the minimum transport prerequisite needed to understand a membrane target and concentrates on target-specific mechanisms, evidence, and failure modes.

## Executive Summary

Many proteins enter the secretory pathway because translation exposes an amino-terminal signal peptide or internal transmembrane segment that is recognized by the signal recognition particle. SRP binds the nascent chain as it emerges from the ribosomal exit tunnel, transiently slows elongation in many systems, and delivers the ribosome-nascent-chain complex to the ER membrane through interaction with the SRP receptor. The ribosome then engages the Sec61 translocon, allowing the growing polypeptide to enter the ER lumen or insert into the membrane while translation continues. This is co-translational targeting: the location of translation and the destination of the protein are coupled before the full protein is made. SRP biology is therefore a translation, protein-targeting, and mRNA-protection problem, not merely a peptide-sorting pathway (Kellogg et al. 2021).

The mRNAs that encode secretory and membrane proteins are enriched on the ER, but ER association is not explained only by the nascent peptide. Some mRNAs remain ER-associated after translation inhibition, some cytosolic-protein mRNAs associate with the ER, and membrane-bound RNA-binding proteins can organize localized translation at organelle surfaces (Béthune et al. 2019; Das et al. 2021). These observations expand the older view of rough ER as a passive landing site for signal-peptide-bearing ribosomes. The ER is better understood as a large membrane platform that coordinates translation, translocation, membrane-protein biogenesis, mRNA surveillance, RNA decay, lipid metabolism, calcium handling, stress signaling, and physical contacts with other organelles.

Organelle-associated translation also occurs at mitochondria and chloroplasts, but the phrase has two distinct meanings. Mitochondria and chloroplasts translate their own organellar mRNAs inside the organelle or plastid compartment. In addition, many nuclear-encoded mRNAs that produce organellar proteins are translated in the cytosol while associated with the outside surface of mitochondria or chloroplasts, often near import channels or contact sites. Plant chloroplast and mitochondrial mRNA metabolism is further shaped by organellar RNA processing and modification (Manduzio and Kang 2021). Recent studies also link RNA structural elements, including G-quadruplexes, to mitochondria-localized mRNA translation and energy metabolism (Dumas et al. 2025). The evidence supports local coupling between translation and organelle function, but the mechanisms and generality vary across organisms, cell types, and transcript classes.

Endosomes and other motile membrane compartments can function as translation platforms. The strongest local example shows late endosomes carrying translation machinery and supporting synthesis that sustains axonal mitochondria (Cioni et al. 2019). This chapter uses that experiment to define an endosome-targeting mechanism and its evidence; the broader neural consequences belong to [Chapter 103](chapter1098.md), and comparative developmental or polarized-cell programs belong to [Chapter 76](chapter1071.md).

Targeted translation also creates compartment-specific quality-control problems. A ribosome can stall during translocon engagement, a nascent membrane protein can fail topology or folding, an organelle-associated transcript can be translated without productive import, or a compartment-bound RNA can remain localized but translationally inactive. ER-associated decay, ribosome quality control, organelle stress responses, and local RNP remodeling determine whether these complexes resume translation, are released, or are degraded. Generic transport-RNP assembly and remodeling are prerequisites supplied by [Chapter 74](chapter1069.md).

The main interpretation caution is that localization does not automatically mean local translation, and local translation does not automatically mean functional regulation. A convincing claim usually requires multiple evidence types: direct RNA localization, ribosome or nascent-chain evidence at the same site, perturbation of the localization mechanism, rescue by localization-competent constructs, and a biological consequence that cannot be explained only by global translation or organelle abundance.

## Concept Inventory

- **Co-translational targeting:** targeting of a ribosome-nascent-chain complex while the polypeptide is still being synthesized. In this chapter the canonical example is SRP-mediated delivery of secretory and membrane proteins to the ER.
- **Signal peptide:** a short hydrophobic amino-acid segment, often near the amino terminus of a secretory protein, that directs the translating ribosome to the ER. Signal peptides are decoded as nascent-chain information, not as RNA sequence signals.
- **Signal recognition particle:** an RNP that recognizes signal peptides or signal-anchor sequences emerging from the ribosome, helps pause or coordinate elongation, and docks the ribosome-nascent-chain complex at the ER through the SRP receptor.
- **Translocon:** a protein-conducting channel, represented by Sec61 in eukaryotic ER membranes, that allows a growing polypeptide to enter the ER lumen or insert into the lipid bilayer.
- **ER-associated translation:** translation occurring on or near the ER membrane. It includes classical rough-ER translation of secretory proteins, but also translation of some cytosolic and regulatory proteins on ER-associated ribosomes.
- **Membrane-associated RNA-binding protein:** an RNA-binding protein physically anchored to a membrane or membrane-associated complex. These proteins can recruit, repress, activate, or remodel mRNAs at organelle surfaces.
- **Organelle-associated translation:** translation spatially coupled to an organelle. The phrase can mean organelle-internal translation of organellar mRNAs, or cytosolic translation of nuclear-encoded mRNAs at the organelle surface.
- **Compartment-associated local translation:** protein synthesis demonstrated at a membrane-bounded compartment, such as an endosome or organelle surface, rather than inferred from RNA enrichment alone.
- **Target-coupled RNP remodeling:** changes in an mRNA-protein complex that occur upon membrane or organelle docking and alter translation, import, surveillance, or release.
- **ER-associated RNA decay:** decay or surveillance of mRNAs at or near the ER, often coupled to translation, translocation load, unfolded-protein responses, or membrane-associated ribonucleases.
- **Interpretation boundary:** enrichment of an mRNA in a purified organelle fraction, microscopy spot, or proximity-labeling dataset is an observation of association. It becomes a mechanism only after direct tests show recruitment, translation, and functional consequence.

## What to Know Before Reading This Chapter

Translation begins with initiation, proceeds through elongation, and ends with termination and ribosome recycling. Earlier chapters introduced cap-dependent initiation, ribosomal decoding, elongation factors, termination, ribosome-associated quality control, and the distinction between mRNA abundance and translation efficiency. This chapter assumes that background but redefines the cell biological frame: where a ribosome translates can matter as much as how fast the ribosome translates.

The endoplasmic reticulum is a membrane network contiguous with the nuclear envelope. The rough ER is studded with ribosomes because many secretory and membrane proteins are translated there. The smooth ER lacks dense ribosome coverage and is enriched for lipid metabolism and calcium handling, but the rough versus smooth distinction is a morphology shorthand rather than a strict molecular boundary. A single ER network can support protein translocation, mRNA decay, stress signaling, and contact-site functions.

Mitochondria and chloroplasts have bacterial ancestry and retain their own genomes and translation systems. However, most mitochondrial and chloroplast proteins are encoded in the nucleus and translated by cytosolic ribosomes before import into the organelle. This dual genetic origin creates a coordination problem: nuclear mRNA translation, organellar translation, import, assembly, and organelle state must be matched.

The term localized translation should be used narrowly. An mRNA can be localized without being translated, and a protein can be transported to a compartment after being made elsewhere. For this chapter, the claim must connect synthesis to an ER, mitochondrial, chloroplast, endosomal, or other membrane-bounded target. Nascent-peptide reporters, compartment-specific ribosome profiling, proximity labeling, fractionation, and live imaging can contribute, but no single assay proves targeting, translation, and function simultaneously. General transport-dynamics methods are treated in [Chapter 74](chapter1069.md).

## 75.1. Signal recognition and ER targeting

The best-understood route from translation to a membrane is the signal recognition particle pathway. The signal recognition particle, abbreviated SRP, is a ribonucleoprotein complex that recognizes hydrophobic signal sequences in nascent polypeptides. In eukaryotes, SRP contains a structured RNA and multiple proteins. The RNA is not a passive scaffold: it helps organize the particle, contributes to the conformational cycle, and participates in the timing of handoff to the SRP receptor. The protein subunits recognize the ribosome and the emerging hydrophobic segment. The result is a molecular bridge between an mRNA being translated and the ER membrane.

![Figure 75.1. SRP-Coupled ER Targeting](../assets/figures/chapter1070_figure1.png)

**Figure 75.1. SRP-Coupled ER Targeting.** SRP-mediated co-translational targeting couples translation to ER entry. A signal peptide is decoded as protein sequence, emerges from the ribosome exit tunnel, recruits the signal recognition particle, and directs the ribosome-nascent-chain complex to the SRP receptor and Sec61 translocon at the ER membrane. The mRNA becomes ER-associated because it remains attached to the ribosome, not because the mRNA itself carries an ER-targeting sequence.

The causal sequence begins in the cytosol. A ribosome initiates translation on an mRNA. If the encoded protein contains an ER signal peptide near the amino terminus, the signal peptide emerges from the ribosomal exit tunnel after the first segment of the polypeptide has been synthesized. SRP binds this exposed hydrophobic segment and the ribosome. SRP binding reduces the chance that the hydrophobic segment will aggregate in the cytosol or be incorrectly released. In many textbook treatments SRP is said to pause translation. A more precise statement is that SRP coordinates elongation with targeting; the strength and duration of elongation slowing vary with species, substrate, and experimental system. SRP then binds the SRP receptor on the ER membrane. GTP binding and hydrolysis by SRP and SRP receptor drive conformational changes that transfer the ribosome-nascent-chain complex to the Sec61 translocon. Once the ribosome is docked at the translocon, elongation resumes or continues, and the growing polypeptide enters the channel.

This mechanism explains why a secreted protein such as a peptide hormone, antibody chain, or extracellular matrix protein can be synthesized by a cytosolic ribosome yet enter the ER lumen before release into the cytosol. The mRNA itself does not usually encode an ER-targeting peptide in its nucleotide sequence. Instead, translation converts the nucleotide sequence into a nascent polypeptide signal, and the nascent polypeptide recruits the targeting machinery. The mRNA is carried along because the ribosome remains attached to the mRNA. Thus ER localization of many secretory-protein mRNAs is a consequence of a nascent-chain signal and ribosome docking.

The same pathway handles many integral membrane proteins, but membrane insertion adds topology decisions. An internal signal-anchor sequence can initiate translocation and remain as a transmembrane helix. Stop-transfer sequences can halt movement of a segment through the translocon and partition a hydrophobic helix into the lipid bilayer. Multiple transmembrane segments are inserted through repeated cycles of opening, lateral gating, and topological orientation. Translation, translocation, membrane insertion, glycosylation, disulfide formation, and chaperone-assisted folding are therefore coupled. A mutation that changes hydrophobicity, charge distribution, or signal-peptide cleavage can alter not only targeting but also folding, ER quality control, and protein abundance.

The evidence basis for SRP targeting is unusually strong because it combines biochemical reconstitution, structural biology, genetics, ribosome-nascent-chain complexes, and cell imaging. The local [Chapter 75](chapter1070.md) bibliography includes Kellogg et al. (2021) as a review anchor for SRP roles in co-translational targeting and mRNA protection. That review is useful for the current consensus that SRP is not simply a postal code reader for proteins. SRP also protects mRNAs and nascent chains from mistargeting, aggregation, and quality-control outcomes that can follow delayed targeting. Details of the classical SRP discovery, the Sec61 channel, and GTPase handoff require additional landmark citations not yet present in the local bibliography. Final reference item: add verified primary and structural references for mammalian SRP, SRP receptor, and Sec61 translocon mechanisms.

Several boundary cases prevent overgeneralization. First, not every ER protein uses the same targeting route. Tail-anchored proteins have a single transmembrane segment near the carboxyl terminus that emerges only after termination; they often require post-translational targeting systems rather than classical SRP co-translational targeting. Second, some small secretory proteins, weak signal sequences, and specialized substrates can use alternative or partially redundant routes. Third, some mRNAs encoding cytosolic proteins associate with the ER for reasons unrelated to signal peptides. Finally, viral RNAs and synthetic mRNAs can heavily load ER or secretory pathways when they encode membrane or secreted antigens, but delivery, innate immune sensing, and codon design are separate layers from SRP targeting.

The cross-chapter handoff is direct. Translation-initiation chapters explain how the ribosome starts at the correct open reading frame; this section explains how the nascent chain produced by that ribosome changes where translation continues. Protein folding and ER stress chapters explain what happens when the translocation and folding load exceeds ER capacity.

## 75.2. Membrane and secretory protein mRNA translation

Membrane and secretory protein mRNA translation refers to the synthesis of proteins that enter the ER lumen, become embedded in the ER membrane, or move through the secretory pathway to the Golgi, lysosome, plasma membrane, extracellular space, or secreted vesicles. The main object is not simply a class of proteins. It is a coupled production line in which a single mRNA can be read by multiple ribosomes while nascent chains enter a membrane-bound maturation environment.

The classical example is an mRNA encoding a secreted immunoglobulin chain in a plasma cell. The mRNA is exported from the nucleus and engages cytosolic ribosomes. Once a signal peptide is translated, SRP recruits the ribosome to the ER. As elongation continues, the nascent chain passes into the ER lumen, where signal peptidase can remove the signal peptide, N-linked glycosylation can begin on appropriate Asn-X-Ser/Thr motifs, disulfide-bond formation can occur, and chaperones can inspect folding. If the polypeptide folds and assembles properly, it moves onward through the secretory pathway. If folding fails, ER-associated degradation and stress pathways can reduce the burden.

For an mRNA encoding a membrane receptor, the same broad logic applies, but the product must be inserted with correct topology. The ribosome and translocon must coordinate alternating luminal, membrane-spanning, and cytosolic domains. Positively charged residues, hydrophobic segments, translation kinetics, and translocon-associated factors influence orientation. The mRNA's translation speed can affect folding and membrane insertion because nascent domains appear sequentially. Codon usage, RNA structure, RNA modifications, and initiation frequency may therefore affect secretory protein output, although claims about any specific mRNA require direct evidence. Lin and Kuang (2024) provide a disease-oriented review of RNA modification-mediated translation regulation; this chapter uses that reference only for the general principle that mRNA modifications can tune translation in context, not as direct evidence for every ER-targeted transcript.

A key modern insight is that ER-associated mRNA translation is broader than secretory protein synthesis. Membrane-associated RNA-binding proteins can recruit mRNAs to organelles, hold transcripts in a repressed state, or couple translation to local signaling. Béthune et al. (2019) reviewed membrane-associated RNA-binding proteins as organizers of organelle-coupled translation. Das et al. (2021) reviewed intracellular mRNA transport and localized translation as a general cell biological system. Together these reviews support a wider definition of ER-associated translation: the ER can be an address, a scaffold, a quality-control site, and a regulatory platform.

One boundary case is the observation that some mRNAs remain near ER membranes even when translation is inhibited. Such observations argue for RNA- or RNP-mediated membrane association, but they must be interpreted carefully. Translation inhibitors have different effects. Cycloheximide freezes many elongating ribosomes and can artificially stabilize ribosome-membrane association. Puromycin promotes premature chain release and can detach some ribosome-nascent-chain complexes. Harringtonine and lactimidomycin alter initiation or early elongation. A claim that an mRNA is translation-independently ER-associated must therefore specify the inhibitor, timing, dose, cell state, and control transcripts.

Secretory mRNA translation also intersects with therapeutic and vaccine mRNAs. Exogenous mRNAs delivered by lipid nanoparticles or other carriers usually enter the cytosol and use host ribosomes. If the encoded antigen or therapeutic protein contains a signal peptide or membrane anchor, translation can direct the nascent protein into the ER or secretory pathway. Reviews of mRNA vaccine design and delivery, including Leong et al. (2025), Lu et al. (2025), and Teo (2022), provide a broad applied context. However, those reviews should not be used to infer detailed ER-targeting mechanisms unless the specific claim concerns mRNA vaccine design, delivery, antigen expression, or secretory-pathway entry.

The evidence basis for membrane and secretory mRNA translation includes polysome fractionation, ER membrane fractionation, ribosome profiling from membrane fractions, fluorescent nascent-chain reporters, proximity labeling of ribosomes or mRNAs near the ER, and perturbation of SRP, translocon, signal peptides, or RNA-binding proteins. Each method answers a different question. Fractionation can show enrichment but is vulnerable to organelle contamination. Ribosome profiling can show ribosome occupancy but loses spatial information unless combined with compartment purification or proximity labeling. Imaging can show location but may be limited by optical resolution, reporter perturbation, and overexpression. Nascent-chain methods can show local synthesis but may alter translation or folding if tags are too large or poorly placed.

> **Box 75.1. Evidence Ladder for a Membrane-Targeted Translation Claim**
>
> 1. The endogenous mRNA is enriched at the proposed site.
> 2. Ribosomes or translation factors are present at that site.
> 3. Nascent protein synthesis from that specific mRNA is detected locally.
> 4. A defined RNA element, nascent peptide, RNA-binding protein, receptor, or compartment feature explains recruitment.
> 5. Perturbing the mechanism disrupts local translation without merely destroying the cell or globally blocking translation.
> 6. Rescue restores localization or local synthesis.
> 7. A local biological phenotype changes in the predicted direction.

The most defensible models combine these methods. For example, an ER-localization claim is stronger when the endogenous mRNA is enriched near ER markers, the nascent protein appears at the ER, signal-peptide mutation disrupts localization, localization is restored by a wild-type signal peptide, and protein maturation depends on ER translocation. A weaker claim would be based only on bulk RNA-seq of an ER fraction.

> **Box 75.2. Do Not Confuse These Pairs**
>
> - Secretory mRNA versus any mRNA encoding an extracellular protein fragment: only mRNAs whose translation exposes a signal peptide engage the SRP-ER pathway.
> - Mitochondrial mRNA versus nuclear mRNA encoding a mitochondrial protein: the former is transcribed and translated inside the organelle; the latter uses cytosolic ribosomes and may associate with the organelle surface.
> - Compartment association versus local translation: an mRNA found on an endosome or organelle surface may be stored, transiting, or awaiting a signal rather than being actively translated.
> - Proximity labeling versus direct physical binding: a molecule marked by a proximity enzyme was nearby; it was not necessarily bound to or functionally engaged with the labeled complex.

## 75.3. Organelle-associated translation at mitochondria and chloroplasts

Mitochondria and chloroplasts complicate the concept of localized translation because they contain their own translation systems while also depending heavily on cytosolic translation of nuclear genes. Mitochondrial genomes encode a small number of core oxidative phosphorylation proteins, rRNAs, and tRNAs in most animals, with broader variation across eukaryotes. Chloroplast genomes encode photosynthetic and gene-expression components in plants and algae. These organellar mRNAs are transcribed, processed, and translated inside the organelle or plastid. At the same time, the vast majority of mitochondrial and chloroplast proteins are encoded by nuclear mRNAs, translated by cytosolic ribosomes, and imported after or during synthesis.

The first meaning of organelle-associated translation is organelle-internal translation. Mitochondrial ribosomes synthesize hydrophobic membrane proteins that are inserted into the inner mitochondrial membrane. Chloroplast ribosomes synthesize photosystem, cytochrome, ATP synthase, and gene-expression proteins that must assemble with nuclear-encoded partners. These translation systems have bacterial ancestry but have been extensively remodeled. Their mRNAs often have unusual untranslated regions, editing events, polyadenylation logic, and protein-dependent stabilization mechanisms. Manduzio and Kang (2021) review RNA methylation in plant chloroplasts and mitochondria, supporting the broader principle that organellar RNA metabolism is regulated by chemical and protein-mediated layers. Details of mitochondrial and chloroplast ribosome structures, genetic codes, and translation factors are handled more fully in organellar RNA chapters.

The second meaning is cytosolic translation at the organelle surface. Many nuclear-encoded mitochondrial proteins are translated near mitochondria, which can promote efficient import, local quality control, and coordination with organelle state. A useful example is a nuclear mRNA encoding a mitochondrial inner-membrane protein. Translation begins on cytosolic ribosomes. The nascent protein contains a mitochondrial targeting sequence or internal targeting information. Cytosolic chaperones and import receptors recognize the nascent or newly synthesized polypeptide, and the protein enters through translocase complexes in the outer and inner mitochondrial membranes. If the mRNA and ribosome are already near the mitochondrial surface, the distance between synthesis and import is reduced.

The logic for chloroplasts is similar but plant-specific. A nuclear mRNA encoding a chloroplast photosynthetic protein is translated in the cytosol, and the protein is imported into the chloroplast using an amino-terminal transit peptide recognized by the TOC and TIC import systems. Localizing the mRNA near chloroplasts could help coordinate translation with light, redox state, protein complex assembly, or stress. However, the extent and mechanism of chloroplast-surface translation differ across cell types and remain less uniformly established than classical ER targeting. Final reference item: add verified plant-local-translation references for nuclear-encoded chloroplast protein mRNAs and import-coupled translation.

Recent studies add RNA-structural regulation to this picture. Dumas et al. (2025) report that RNA G-quadruplexes can control mitochondria-localized mRNA translation and energy metabolism. A G-quadruplex is a four-stranded nucleic-acid structure formed by guanine-rich sequences through stacked G-quartets. In mRNAs, G-quadruplexes can influence translation, localization, RNA-protein binding, and stability. The key teaching point is not that every mitochondrial mRNA uses a G-quadruplex. Rather, RNA structure can be part of the localization and translation code for specific transcripts.

Organelle-associated translation has functional advantages. It can concentrate protein synthesis near import channels, reduce exposure of hydrophobic proteins to the cytosol, coordinate stoichiometry between organelle-encoded and nuclear-encoded subunits, and allow organelle stress to feed back on translation. In neurons and other polarized cells, local synthesis near mitochondria can support energy metabolism in distant processes. In plants, chloroplast development and photosynthetic acclimation require tight coordination between nuclear and plastid gene expression.

The evidence basis is difficult because mitochondria and chloroplasts are abundant, sticky, and physically connected to other membranes. Purified mitochondrial fractions can contain ER-associated ribosomes, and ER-mitochondria contact sites can make localization ambiguous. Chloroplast preparations can contain cytosolic contaminants or ruptured organelles. Imaging can distinguish organelle proximity but may not prove import coupling. Ribosome profiling can identify translated open reading frames but often lacks spatial resolution. Stronger claims use orthogonal tests: endogenous mRNA imaging, ribosome proximity labeling, organelle-surface translation reporters, import-defective mutants, RNA localization element perturbation, and measurements of organelle function.

Do not overgeneralize from organellar mRNA translation to nuclear mRNA translation at organelle surfaces. An mRNA encoded by the mitochondrial genome is not transported from the nucleus and does not use cytosolic ribosomes. Conversely, a nuclear mRNA encoding a mitochondrial protein is not a mitochondrial mRNA in the genomic sense. That distinction is essential for interpreting sequencing data, genetic perturbations, and disease variants.

![Figure 75.2. Four Membrane and Organelle Targeting Modes](../assets/figures/chapter1070_figure2.png)

**Figure 75.2. Four Membrane and Organelle Targeting Modes.** Membrane-targeted translation can be driven by nascent peptide recognition, an RNA-associated tether, import coupling, or a motile membrane platform. Four panels compare classical rough-ER translation, mitochondrial-surface translation of a nuclear-encoded protein, chloroplast-surface translation of a nuclear-encoded protein, and endosome-associated translation. An inset distinguishes organelle-internal translation from cytosolic translation at the surface. Each mode labels its targeting cue, ribosome location, protein destination, strongest evidence, and boundary case.

## 75.4. Endosome and compartment-associated mRNA targeting and translation

Endosomes are membrane-bounded sorting and signaling compartments that move along cytoskeletal tracks and form contacts with mitochondria, lysosomes, and the ER. An endosome-associated mRNA can arrive through an RNA-binding adaptor, an RNP-endosome tether, or coupling to translation machinery at the membrane. The mechanistic question is not merely whether an RNA spot overlaps an endosomal marker. A complete model must identify the endosomal state, the molecular tether, the translation state of the RNA, the locally produced protein, and the function that depends on synthesis at that compartment.

The FERRY complex illustrates targeting at early endosomes. FERRY is associated with Rab5-positive early endosomes and can link selected mRNAs to the endosomal system (Schuhmacher et al. 2023). This establishes a physical route by which an mRNP can be coupled to a moving membrane compartment, but association alone does not prove that every FERRY-bound RNA is translated on the endosome. Translation competence may change as the endosome matures, encounters signaling inputs, or forms contacts with another organelle.

Late endosomes provide direct translation evidence. Cioni et al. (2019) showed that late endosomes can act as mRNA translation platforms and support mitochondrial function in axons. The endosome-specific lesson is that a motile compartment can bring RNA, ribosomes, and regulatory factors into proximity with a local organelle need. The neural consequences of this mechanism are integrated in [Chapter 103](chapter1098.md); this section retains the experiment because it establishes an endosomal translation platform and a compartment-coupled functional readout.

A target-specific causal sequence has five parts. First, an mRNP becomes physically coupled to an endosomal or related membrane compartment. Second, compartment maturation, receptor signaling, organelle contact, calcium, or kinase activity changes the molecular environment. Third, the RNP gains or loses translation competence at the target. Fourth, nascent synthesis occurs while the RNA remains spatially associated with the compartment. Fifth, perturbing the tether or local translation changes a compartment-proximal function without equivalently reducing global RNA abundance or protein synthesis. The general machinery that builds and transports the RNP is treated in [Chapter 74](chapter1069.md).

Other membrane-bounded targets can use related logic, but they should not be collapsed into one endosome mechanism. Lysosome-proximal translation can couple nutrient or stress signaling to protein production. ER-endosome and mitochondria-endosome contact sites can create ambiguous proximity in imaging or fractionation. Secretory vesicles and phagosomal compartments can recruit RNAs or ribosomes in specialized cells. Developmental, migrating-cell, and polarized-cell comparisons belong to [Chapter 76](chapter1071.md), while neuron- and glia-specific integration belongs to [Chapter 103](chapter1098.md).

Evidence must separate four alternatives: an RNA can be transported on a compartment but remain repressed; a ribosome can be nearby but translate a different RNA; a mature protein can arrive after synthesis elsewhere; or the compartment itself can change abundance or position after perturbation. Strong experiments combine endogenous RNA localization, compartment identity, nascent-chain or compartment-specific ribosome evidence, tether perturbation, rescue, and a local functional assay. The method-specific caveats are developed in [Section 75.6](chapter1070.md).

## 75.5. RNP remodeling, quality control, and stress

Membrane targeting changes the quality-control problems faced by an mRNP. At the ER, a ribosome can fail to dock, stall while engaged with Sec61, translate a topologically defective membrane segment, or continue producing a nascent chain that cannot fold in the lumen. At mitochondria or chloroplasts, a nuclear-encoded product can be synthesized near an import site but fail recognition, translocation, processing, or assembly. At endosomes, a transcript can remain tethered while translation is repressed or can be released from the compartment before productive synthesis. Each failure couples RNA state to a membrane-specific protein-biogenesis checkpoint.

ER-associated RNA surveillance is the best-developed example in this chapter. Secretory and membrane protein synthesis imposes translocation and folding load immediately. When targeting or translocation fails, ribosome-associated quality control can act on the stalled complex; when the ER folding environment is overloaded, stress pathways can reduce global translation and change the stability or translation of selected ER-associated mRNAs. Ottens et al. (2024) review RNA decay pathways at the ER, showing that membrane-localized decay can tune secretory-pathway production and remove problematic transcripts rather than serving only as generic cytosolic cleanup.

RNP remodeling at a membrane target should be stated as a local molecular transition. An endosome-associated adaptor can recruit an mRNA, compartment maturation can exchange tethering or translation factors, and an organelle contact can expose the RNP to kinases, metabolites, calcium, or stress signals. At the ER, translation-independent RNA anchors can maintain association after nascent-chain release, whereas translocon or ribosome release can return other transcripts to the cytosol. The complete grammar of repressor exchange, motor adaptors, granule assembly, anchoring, and release belongs to [Chapter 74](chapter1069.md).

Stress must be assigned to the correct layer. A global integrated stress response can reduce initiation throughout the cytosol, whereas ER stress can additionally alter translocon load, ER-localized decay, and secretory-pathway capacity. Mitochondrial or chloroplast stress can change import demand, organelle translation, redox state, and the value of local cytosolic synthesis. Endosome maturation or lysosomal stress can change the identity and signaling state of a compartment that carried an mRNA. A change in local translation during stress is therefore not automatically evidence for a target-specific checkpoint.

The safest designs measure the chain from target to outcome: total and compartment-associated mRNA, ribosome occupancy or nascent synthesis at the target, target morphology and abundance, mature protein localization and function, and markers of global versus compartment-specific stress. A decrease in protein after perturbing a tether can otherwise reflect loss of RNA, global translation inhibition, failed import, protein degradation, or organelle damage. Developmental deployment of these checkpoints belongs to [Chapter 76](chapter1071.md), and neuronal or glial consequences belong to [Chapter 103](chapter1098.md).

## 75.6. Methods and caveats for membrane and organelle targeting

The methods used to study localized translation fall into six broad classes. The first class is physical fractionation. Cells are broken, membranes or organelles are separated by centrifugation or affinity purification, and RNA or ribosomes are measured in each fraction. Fractionation can identify candidate ER-, mitochondrial-, chloroplast-, or endosome-associated mRNAs. Its weakness is contamination. ER and mitochondria form contact sites, ribosomes can remain attached after lysis, and fragile compartments can rupture. A fractionation result is therefore a starting point, not a final localization mechanism.

The second class is imaging. Fluorescence in situ hybridization can detect endogenous mRNAs, and live-cell tags can follow engineered RNAs. Nascent-chain reporters can show where a protein is being synthesized. Imaging preserves spatial context, but it can be limited by resolution, probe accessibility, fixation artifacts, phototoxicity, and reporter design. A bright RNA spot near an organelle may be touching the organelle, passing by it, or projected onto it in a two-dimensional image.

The third class is ribosome profiling and related translation assays. Ribosome profiling measures ribosome-protected mRNA fragments and can infer translation at codon-scale resolution. When combined with compartment purification or proximity-specific ribosome labeling, it can suggest where translation occurs. But ribosome footprints do not intrinsically preserve cellular location, and stress during sample preparation can change ribosome positions. The user should distinguish ribosome occupancy from productive protein synthesis.

The fourth class is proximity labeling. Enzymes targeted to organelles can label nearby RNAs, RNA-binding proteins, or ribosomes. These methods can capture transient proximity and reduce the need for harsh purification. Their weakness is radius and timing. A molecule labeled near an organelle may not be functionally associated with translation there. Labeling enzymes can also perturb the compartment they mark.

The fifth class maps target-specific tethers and RNP composition. CLIP-family assays can identify an RNA-binding protein on candidate organelle-associated transcripts, and affinity or proximity approaches can identify an endosomal adaptor or membrane-bound RNP complex. Such maps nominate a tether; they do not establish that binding recruits the transcript to the membrane or permits translation there. The complete tutorial for transport-RNP and localization-dynamics measurement belongs to [Chapter 74](chapter1069.md).

The sixth class is perturbation and rescue. This is the class that turns association into causality. A signal peptide can be mutated. An RNA localization element can be deleted or moved. An RNA-binding protein can be depleted and rescued with wild-type or binding-defective versions. A transcript can be tethered to an organelle. Translation can be locally blocked or globally preserved. The most informative experiments perturb localization without changing protein sequence, or perturb translation without changing mRNA localization.

Several interpretation caveats recur across the chapter. Localization enrichment can reflect organelle abundance rather than selective recruitment. ER-mitochondria and endosome-organelle contacts can make a transcript appear assigned to either partner. Highly expressed mRNAs can appear in many compartments because detection is easier. Translation inhibitors can stabilize or release ribosome-membrane complexes differently. Overexpressed reporters can saturate targeting and quality-control pathways, and organelle purification can redistribute ribosomes after lysis. These target-specific confounders must be controlled before broader RNA-seq or imaging interpretation is invoked.

Good interpretation asks a target-specific sequence of questions. Is the mRNA on the cytosolic surface, inside the organelle, or merely in a contacting membrane fraction? Is a ribosome translating it at that target? Is the encoded protein synthesized there rather than imported after synthesis elsewhere? Does a nascent peptide, RNA element, RBP, endosomal adaptor, import receptor, or stress pathway create the association? Does disrupting that mechanism change a target-proximal function while preserving global abundance, translation, cell health, and organelle morphology? These questions define the evidence ladder for membrane and organelle targeting.

**Table 75.1. Method Classes for Membrane and Organelle Targeting.** No single method proves local translation. Strong inference comes from combining spatial, translational, mechanistic, and functional evidence.

| Method class | What it measures | What it cannot prove alone | Key artifact | Best complementary test |
| --- | --- | --- | --- | --- |
| **Organelle or membrane fractionation** | mRNA or ribosome enrichment in a subcellular fraction | Local translation; shows co-purification, not synthesis at site | Organelle rupture, contact-site mixing, and sticky membranes co-purifying unrelated RNA | RNA imaging in intact cells to confirm spatial enrichment |
| **RNA imaging (FISH or live RNA tag)** | Spatial distribution of endogenous or tagged mRNA | Whether the mRNA is being translated at that location | Probe inaccessibility, fixation artifacts, and 2D projection of 3D proximity | Nascent-chain reporter at the same subcellular site |
| **Live nascent-chain imaging** | Active protein synthesis and ribosome engagement at a site | mRNA identity or mechanism of recruitment to that site | Bulky fluorescent tags altering mRNA localization or translation rate | Matched RNA imaging probe for the same transcript |
| **Ribosome profiling with compartment enrichment** | Ribosome-protected footprints indicating translation, often at codon resolution | Where translation occurred; lysis strips spatial information | Stress during lysis shifts ribosome positions; contaminating compartments add noise | Proximity-specific ribosome labeling in intact or lightly permeabilized cells |
| **Proximity labeling** | Molecules within the labeling radius of an enzyme-tagged organelle or protein | Direct binding or functional involvement in translation | Labeling radius is 10–20 nm or larger; enzyme can perturb the compartment it marks | CLIP or RNP-MaP to confirm direct RNA-protein contact |
| **Target-specific CLIP or tether mapping** | RNA contact with a membrane-associated RBP, endosomal adaptor, or import-coupled complex | Recruitment to the membrane or translational output at that target | Cross-linking efficiency and indirect complex recovery can misassign the tether | Imaging and perturbation-rescue experiments at the same compartment |
| **Perturbation and rescue** | Causal requirement for a factor, element, or compartment in local translation | Mechanism; phenotypes can arise from off-target or global effects | Loss-of-function can reduce mRNA abundance, global translation, or cell health independently of local synthesis | Rescue with localization-competent but sequence-altered constructs that preserve protein identity |

## Recent Consensus

The current consensus is that the SRP pathway is the canonical route for co-translational ER targeting of many secretory and membrane proteins. SRP recognizes nascent peptide information, docks ribosome-nascent-chain complexes at the ER through the SRP receptor, and hands the complex to the translocon (Kellogg et al. 2021). This mechanism remains a foundation for understanding the rough ER.

A second consensus is that ER-associated translation is broader than the classical signal-peptide model. The ER is an RNA and translation platform, and membrane-associated RNA-binding proteins can organize organelle-coupled translation for selected transcripts (Béthune et al. 2019; Das et al. 2021).

A third consensus is that mitochondria, chloroplasts, endosomes, and other compartments can couple selected mRNAs to local translation, but association, ribosome engagement, productive synthesis, and local function are separate evidentiary steps. Developmental and cell-type deployment of this principle belongs to [Chapter 76](chapter1071.md), and neuronal or glial integration belongs to [Chapter 103](chapter1098.md).

A fourth consensus is methodological: no single assay is sufficient for strong local-translation claims. Imaging, biochemical fractionation, ribosome profiling, RNP mapping, proximity labeling, perturbation, and rescue each answer different parts of the mechanism.

## Open Questions, Controversies, Deprecated Models, and Common Misconceptions

Open questions:

- How much ER-associated translation is driven by nascent peptides versus RNA elements and RNA-binding proteins? The classical SRP mechanism is secure, but the transcript-specific rules for translation-independent ER association remain incompletely mapped.
- How broadly mitochondrial- and chloroplast-surface translation applies to nuclear-encoded organellar proteins? Local translation near organelles is plausible and supported for selected systems, but the field still needs systematic comparisons across organisms, cell types, and metabolic states.
- Which endosomal identities and maturation states support mRNA tethering, ribosome engagement, and productive local synthesis, and how are those states changed by organelle contacts or stress?

Common misconceptions:

- "An mRNA found in an organelle fraction is locally translated there." Fractionation shows association or co-purification. Local translation requires ribosome and nascent-protein evidence at the site.
- "All mRNAs encoding secreted proteins contain RNA localization signals for the ER." Many are ER-associated because the nascent peptide recruits SRP and the ribosome carries the mRNA to the ER.
- "An mRNA tethered to an endosome is necessarily translated there." Endosomal association can represent transport or storage; compartment-linked ribosome and nascent-chain evidence is required.